Participants receive QPS and answer questions from physician. At follow up visit, participants receive both QPS and GIS.

Participants receive GIS and answer questions from physician. At follow up visit, participants receive both QPS and GIS.

Informational Intervention

Questionnaire Administration

Joseph A Arthur

This trial studies how well information materials work in helping communication between physicians and participants with cancer that has spread to other places in the body and their caregivers. Approaches that encourage participants to actively participate and ask appropriate questions during their visit may be important to enhance their understanding of their illness and empower them to make important decisions regarding their medical care.

PRIMARY OBJECTIVES:

I. To compare patients' perception of helpfulness in communicating with their physicians between a question prompt sheet (QPS) and a general information sheet (GIS).

SECONDARY OBJECTIVES:

I. To compare caregivers' perception of helpfulness in communicating with their physicians between the QPS and the GIS.

II. To examine the level of patients' and caregivers' overall satisfaction with the consultation with the use of the QPS versus the GIS.

III. To examine physicians' views about the information material and overall satisfaction with the use of the QPS versus the GIS.

IV. To explore how the use of QPS affects the average speaking time of patient or physician during the consultation visit.

V. To establish demographic and clinical predictors of patients' perception of helpfulness of a QPS.

VI. To examine the overall patients' preference between the QPS and GIS in an open label phase.

VII. To compare the change in patient anxiety state with the use of the QPS versus the GIS.

VIII. To explore the factors underlying patients' preferences for the QPS or GIS.

OUTLINE: Participants are randomized into 1 of 2 groups.

GROUP I: Participants receive QPS and answer questions from physician. At follow up visit, participants receive both QPS and GIS.

GROUP II: Participants receive GIS and answer questions from physician. At follow up visit, participants receive both QPS and GIS.

RCT of QPS vs General Information Sheet

A Randomized Controlled Trial of Two Different Information Materials in Patients With Advanced Cancer

Standard statistics including mean, standard deviation, median, range, frequency and percentage will be summarized for variables of interest, such as patients' demographics, clinical characteristics, anxiety state, patients'/caregivers' views about the information material, patients' satisfaction, physicians' views about the information material and consultation, patients' preferences for information, patient preferences for level of involvement in decision-making and patients' overall preference between the question prompt sheet (QPS) and the general information sheet (GIS) at the follow-up visit. Two sample t-test or Wilcoxon rank sum test, whichever appropriate, will be used to compare continuous variables of interest between the QPS and the GIS. Chi-squared test or Fisher's exact test, whichever appropriate, will be used to test for associations between categorical variables and helpfulness of information material.

Sample t-test or Wilcoxon rank sum test, whichever appropriate, will be used.

Two sample t-test or Wilcoxon rank sum test, whichever appropriate, will be used to compare the average speaking time of patient or physician during the consultation visit. Also, general linear model will be applied to assess the effect of QPS on the average speaking time adjusting for clinically and/or statistically important factors.

Univariate/multicovariate logistic regression will be used to evaluate patients' demographic and clinical factors on patients' perception of helpfulness of QPS when dichotomizing the answer to the question 3 in the Patient/Caregiver Assessment Questionnaire ("Agree/Strongly Agree"=Helpful versus the rest).

Will estimate the preference of information material with 95% confidence intervals. Also, univariate/multicovariate logistic regression will be used to evaluate patients' demographic and clinical factors on overall patients' preference between QPS and GIS.

National Cancer Institute (NCI)

M.D. Anderson Cancer Center

Participants complete questionnaires and quality of life assessments, and may also complete interviews over 45 minutes periodically.

Interview

Quality-of-Life Assessment

Xin Shelley Wang

This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.

PRIMARY OBJECTIVES:

I. To examine how the MD Anderson Inventory (MD Anderson Symptom Inventory \[MDASI\]) or other MD Anderson-developed patient reported outcome (PRO) instrument performs in various sample populations including community dwelling adults and patients who have different cancer types, who have undergone various treatments, and who have different and/or more severe symptoms.

II. To evaluate the MDASI or other MD Anderson-developed PRO instrument as an estimate of functional status and quality of life.

III. To assess the impact of symptom severity on standard function and health-related quality of life measures, including both quantitative and qualitative measures (patient interviews).

IV. To assess the pattern and severity of symptoms over multiple time points in order to assay the system's responsiveness to changes due to therapy or disease.

V. To explore the utility of an interactive voice response (IVR) system in enhancing the clinical care of outpatients.

VI. To explore the effect of information from an IVR symptom assessment system on the pattern of care and development of interdisciplinary protocols.

VII. To explore the feasibility of developing symptom management pathways for patients based on these symptom and quality of life data.

OUTLINE:

Participants complete questionnaires and quality of life assessments, and may also complete interviews over 45 minutes periodically.

New Assessment System in Measuring Symptom Distress in Cancer Patients

Measuring the Symptom Distress of Cancer Patients: Development of a New Assessment System

Each item is rated 0 to 10 with 0 = symptom not present or no interference and 10 meaning the symptom severity is as bad as can be imaged or complete interference. The symptom severity and interference sub scales are mean values of the items in each scale. Hence the range of each sub scale is also 0 to 10. Lower values represent a better outcome. Higher values represent a worse outcome. The symptom severity and interference sub scales are not combined to compute a total score.

Mean ratings of 11-point 0-10 scales; lower mean score = better outcome.

6-point 0-5 scale; lower score = better outcome.

Scored on 5-point 1 to 5 scales; combined scores converted to index value for US = -0.573 to 1; higher values = better outcome.

Changes in patients' symptoms over time will be determined by differences in symptom severity scores on the MD Anderson Symptom Inventory MDASI collected at multiple time points. 0 to 10 with 0 = symptom not present or no interference and 10 meaning the symptom severity is as bad as can be imaged or complete interference. The symptom severity and interference sub scales are mean values of the items in each scale. Hence the range of each sub scale is also 0 to 10. Lower values represent a better outcome. Higher values represent a worse outcome. The symptom severity and interference sub scales are not combined to compute a total score.

The European Organization for Cancer Treatment and Research Quality of Life scale (EORTC QLQ-C30) is a quality of life questionnaire that measures five functional areas (physical, social, role, cognitive, and emotional), eight symptoms (fatigue, nausea/vomiting, pain, dyspepsia, sleep disturbance, diarrhea, appetite loss, and constipation), financial impact, and overall quality of life. All of the sub scales and single-item measures range in score from 0 to 100 according to scoring algorithms.

Bayer

Bristol-Myers Squibb

Eli Lilly and Company

Genentech, Inc.

Merck Sharp & Dohme LLC

National Institutes of Health (NIH)

Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Skin and Connective Tissue Diseases

Digestive System Diseases

Lung Neoplasms

Breast Neoplasms

Colonic Neoplasms

Colorectal Neoplasms

Intestinal Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Colonic Diseases

Intestinal Diseases

Physicians (MD or DO) in the oncology departments of participating hospitals will complete a survey. Non-English language proficiency will be assessed by self-assessment using Interagency Language Roundtable (ILR) scale, which the PI has previously used. The physician survey is collected among treating physicians of patients enrolled to MSK IRB approved protocols 12-099 and 12-223 at some of the participating hospitals. For physicians who already completed this survey as part of participation in protocol 12-099 or 12-223, data will be extracted from the respective study's REDCap database.

Audio record the initial visits between patients and their treating physician. Analyze 48 patient-physician dyad recordings using the Roter Interaction Analysis System (RIAS).

The ILR Scale, a non-English language proficiency self-assessment.

survey

Audio record the initial visits between patients and their treating physician

Audio record

Lisa Diamond, MD, MPH

The purpose of this study is to test a method for analyzing interactions between patients and doctors, the Roter Interaction Analysis System (RIAS). The RIAS measures the quality of communication between patients and their cancer doctors.

Physician Use of Non-English Language Skills in Cancer Care

using the RIAS in cancer care across English and Spanish languages will be assessed by evaluating whether this existing, validated coding system 'works' across a language barrier.

Edward-Elmhurst Health System

Johns Hopkins University

Lincoln Medical and Mental Health Center

Queens Cancer Center of Queens Hospital

Memorial Sloan Kettering Cancer Center

Liver Neoplasms

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

Rectal Diseases

Liver Diseases

Patients attend focus groups to help develop patient portal and navigation program. Patients use in-person navigation program. Patients also complete data collection and surveys over 15 minutes via web portal at baseline, 3 months, and 6 months and user experience survey at end of program participation.

Patient Navigation Program

Survey Administration

Tung T Nguyen, MD

This phase I/II trial studies how well patient portal and navigation program work in providing information for Asian American cancer patients. Patient portal and navigation program may help to improve the care provided to Asian American cancer patients.This study is offered in the following languages in addition to English: Chinese (Cantonese or Mandarin) and Vietnamese.

PRIMARY OBJECTIVES:

I. Identify Asian American adults newly diagnosed with colorectal, liver, or lung cancer using a population-based cancer registry.

II. Conduct outreach to these patients to let them know about the availability of information on these cancers, the Patient Cancer OUtreach, Navigation, Technology and Support (COUNTS) web portal, and the Patient COUNTS patient navigation program.

III. Provide patient navigation either virtually or in-person.

OUTLINE:

Patients attend focus groups to help develop patient portal and navigation program. Patients use in-person navigation program. In phase II, patients use an online portal to access navigation program and may choose to have online/virtual navigation support or in-person navigation support. Patients also complete data collection and surveys over 15 minutes via web portal at baseline, 3 months, and 6 months and user experience survey at end of program participation.

Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients

The Patient Cancer OUtreach, Navigation, Technology, and Support (Patient COUNTS) Project: Addressing Care for Asian Americans With Cancer

At least one contact with patient navigator

Positive response(s) to survey item(s) on completion of MD-recommended treatment

Response of "satisfied" or "very satisfied" to survey item on satisfaction with Patient COUNTS navigation program

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
RCT of QPS vs General Information Sheet	NCT03287492	Advanced Malign... Caregiver Physician	Informational I... Informational I... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
New Assessment System in Measuring Symptom Distress in Cancer Patients	NCT00505245	Caregiver Health Care Pro... Malignant Neopl... Physician	Interview Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
RCT of QPS vs General Information Sheet	NCT03287492	Advanced Malign... Caregiver Physician	Informational I... Informational I... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Physician Use of Non-English Language Skills in Cancer Care	NCT02726360	Breast Cancer Colon Cancer Lung Cancer	survey Audio record	21 Years - 80 Years	Memorial Sloan Kettering Cancer Center
Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients	NCT03867916	Caregiver Malignant Neopl... Physician Stage I Colorec... Stage I Liver C... Stage I Lung Ca... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage II Colore... Stage II Liver ... Stage II Lung C... Stage IIA Color... Stage IIA Lung ... Stage IIB Color... Stage IIB Lung ... Stage IIC Color... Stage III Color... Stage III Liver... Stage III Lung ... Stage IIIA Colo... Stage IIIA Lung... Stage IIIB Colo... Stage IIIB Lung... Stage IIIC Colo... Stage IIIC Lung...	Patient Navigat... Quality-of-Life... Survey Administ...	21 Years -	University of California, San Francisco
Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients	NCT03867916	Caregiver Malignant Neopl... Physician Stage I Colorec... Stage I Liver C... Stage I Lung Ca... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage II Colore... Stage II Liver ... Stage II Lung C... Stage IIA Color... Stage IIA Lung ... Stage IIB Color... Stage IIB Lung ... Stage IIC Color... Stage III Color... Stage III Liver... Stage III Lung ... Stage IIIA Colo... Stage IIIA Lung... Stage IIIB Colo... Stage IIIB Lung... Stage IIIC Colo... Stage IIIC Lung...	Patient Navigat... Quality-of-Life... Survey Administ...	21 Years -	University of California, San Francisco

Spots Global Cancer Trial Database for physician

Every month we try and update this database with for physician cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for physician

Every month we try and update this database with for physician cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for physician cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.